(RTTNews) – Caliway Biopharmaceuticals announced that the FDA has granted clearance to proceed with SUPREME-01 or CBL-0301, a global, multicenter, Phase 3 study of CBL-514, the first investigational drug for large-area localized fat reduction. Caliway also plans to submit a Phase